Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Clarithromycin/Clofazimine/Rifabutin

Generic Name: Clarithromycin/Clofazimine/Rifabutin

Overview

No overview information available.

Background

No background information available.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

RHB-204 for the Treatment of Pulmonary Mycobacterium Avium Complex Disease

Phase 3

Terminated

Posted: 2020/11/05

Sponsor:RedHill Biopharma Li...

ID:NCT04616924

Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's Disease

Phase 3

Completed

Posted: 2013/09/26

Sponsor:RedHill Biopharma Li...

ID:NCT01951326

Proof of Concept Study of RHB-104 as Add-On Therapy to Interferon Beta-1a in Relapsing Remitting Multiple Sclerosis (RRMS)

Phase 2

Completed

Posted: 2012/10/30

Sponsor:RedHill Biopharma Li...

ID:NCT01717664

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

RedHill Biopharma to Launch First-Ever Clinical Trial Targeting MAP Infection in Crohn's Disease

3 months ago

RedHill Biopharma plans to initiate an innovative Phase 2 study of RHB-204 in MAP-positive Crohn's disease patients, representing a paradigm shift in treatment by targeting a suspected cause rather than symptoms.

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

Home Terms & Conditions Privacy Policy